Breaking News

Wednesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
U.S. PTAB rules ShockWave's claims of '091 patent 'unpatentable' » 15:46
07/08/20
07/08
15:46
07/08/20
15:46
SWAV

ShockWave Medical

$47.11 /

-0.56 (-1.17%)

, CSII

Cardiovascular Systems

$30.38 /

+0.05 (+0.16%)

The U.S. Patent Trial and…

The U.S. Patent Trial and Appeal Board, or PTAB, ruled against ShockWave Medical (SWAV) in IPR2019-00409: Cardiovascular Systems (CSII) v. Shockwave Medical - U.S. Patent No. 8728091, Shockwave Catheter System With Energy Control. The ruling stated that "Cardiovascular Systems has shown, by a preponderance of the evidence, that claims 1-14 of patent 8,728,091 are unpatentable."

ShowHide Related Items >><<
SWAV ShockWave Medical
$47.11 /

-0.56 (-1.17%)

CSII Cardiovascular Systems
$30.38 /

+0.05 (+0.16%)

SWAV ShockWave Medical
$47.11 /

-0.56 (-1.17%)

06/11/20
Fly Intel: Top five analyst upgrades
06/11/20 Oppenheimer
ShockWave Medical upgraded to Perform at Oppenheimer
06/11/20 Oppenheimer
ShockWave Medical upgraded to Perform from Underperform at Oppenheimer
06/09/20 Canaccord
ShockWave Medical price target raised to $53 from $46 at Canaccord
CSII Cardiovascular Systems
$30.38 /

+0.05 (+0.16%)

06/19/20 Aegis
Cardiovascular Systems initiated with a Buy at Aegis
06/11/20 Needham
Needham upgrades Cardiovascular Systems on 'too compelling' valuation
06/11/20 Needham
Cardiovascular Systems upgraded to Buy from Hold at Needham
SWAV ShockWave Medical
$47.11 /

-0.56 (-1.17%)

CSII Cardiovascular Systems
$30.38 /

+0.05 (+0.16%)

  • 17
    Jun
  • 10
    Jun
  • 15
    Nov
SWAV ShockWave Medical
$47.11 /

-0.56 (-1.17%)

CSII Cardiovascular Systems
$30.38 /

+0.05 (+0.16%)

Over a week ago
Initiation
Cardiovascular Systems initiated with a Buy at Aegis » 11:16
06/19/20
06/19
11:16
06/19/20
11:16
CSII

Cardiovascular Systems

$34.73 /

+0.84 (+2.48%)

Earlier, Aegis analyst…

Earlier, Aegis analyst Nathan Weinstein initiated coverage of Cardiovascular Systems with a Buy rating and $45 price target.

ShowHide Related Items >><<
CSII Cardiovascular Systems
$34.73 /

+0.84 (+2.48%)

CSII Cardiovascular Systems
$34.73 /

+0.84 (+2.48%)

06/11/20
Fly Intel: Top five analyst upgrades
06/11/20 Needham
Needham upgrades Cardiovascular Systems on 'too compelling' valuation
06/11/20 Needham
Cardiovascular Systems upgraded to Buy from Hold at Needham
05/06/20 Lake Street
Cardiovascular Systems price target lowered to $48 from $54 at Lake Street
CSII Cardiovascular Systems
$34.73 /

+0.84 (+2.48%)

CSII Cardiovascular Systems
$34.73 /

+0.84 (+2.48%)

Conference/Events
Piper Sandler to hold a virtual event » 10:00
06/16/20
06/16
10:00
06/16/20
10:00
CSII

Cardiovascular Systems

$34.33 /

+0.43 (+1.27%)

, INSP

Inspire Medical

$87.95 /

+2.69 (+3.16%)

, KIDS

OrthoPediatrics

$48.41 /

+ (+0.00%)

, TCMD

Tactile Systems

$43.00 /

+1.49 (+3.59%)

Midwest Medtech Day…

Midwest Medtech Day Virtual Event will be held on June 16.

ShowHide Related Items >><<
TCMD Tactile Systems
$43.00 /

+1.49 (+3.59%)

KIDS OrthoPediatrics
$48.41 /

+ (+0.00%)

INSP Inspire Medical
$87.95 /

+2.69 (+3.16%)

CSII Cardiovascular Systems
$34.33 /

+0.43 (+1.27%)

CSII Cardiovascular Systems
$34.33 /

+0.43 (+1.27%)

06/11/20
Fly Intel: Top five analyst upgrades
06/11/20 Needham
Needham upgrades Cardiovascular Systems on 'too compelling' valuation
06/11/20 Needham
Cardiovascular Systems upgraded to Buy from Hold at Needham
05/06/20 Lake Street
Cardiovascular Systems price target lowered to $48 from $54 at Lake Street
INSP Inspire Medical
$87.95 /

+2.69 (+3.16%)

05/26/20 Wells Fargo
Inspire Medical price target raised to $95 from $81 at Wells Fargo
05/18/20
Fly Intel: Top five analyst initiations
05/18/20 Lake Street
Inspire Medical initiated with a Buy at Lake Street
05/06/20 Guggenheim
Inspire Medical price target raised to $90 from $80 at Guggenheim
KIDS OrthoPediatrics
$48.41 /

+ (+0.00%)

06/08/20 BTIG
OrthoPediatrics price target raised to $54 from $48 at BTIG
05/06/20 Piper Sandler
OrthoPediatrics trends in April not as bad as feared, says Piper Sandler
03/30/20 Piper Sandler
OrthoPediatrics will bounce back well post COVID-19, says Piper Sandler
03/05/20 Piper Sandler
Piper continues to recommend OrthoPediatrics after Q4 results
TCMD Tactile Systems
$43.00 /

+1.49 (+3.59%)

05/21/20 Piper Sandler
Early diligence on new Tactile Systems CEO very positive, says Piper Sandler
04/07/20 BTIG
Tactile Systems price target lowered to $63 from $72 at BTIG
04/06/20 Piper Sandler
Piper Sandler remains 'constructive' on Tactile Systems after 'solid' Q1 results
01/20/20 Piper Sandler
Lawsuit may drag out into 2021, impact on Tactile 'modest,' says Piper Sandler
TCMD Tactile Systems
$43.00 /

+1.49 (+3.59%)

KIDS OrthoPediatrics
$48.41 /

+ (+0.00%)

INSP Inspire Medical
$87.95 /

+2.69 (+3.16%)

CSII Cardiovascular Systems
$34.33 /

+0.43 (+1.27%)

INSP Inspire Medical
$87.95 /

+2.69 (+3.16%)

INSP Inspire Medical
$87.95 /

+2.69 (+3.16%)

CSII Cardiovascular Systems
$34.33 /

+0.43 (+1.27%)

Over a month ago
Upgrade
Fly Intel: Top five analyst upgrades » 10:09
06/11/20
06/11
10:09
06/11/20
10:09
AAPL

Apple

$349.10 /

-3.51 (-1.00%)

, KDP

Keurig Dr Pepper

$28.99 /

+0.47 (+1.65%)

, CSII

Cardiovascular Systems

$33.69 /

+0.64 (+1.94%)

, KL

Kirkland Lake Gold

$39.54 /

+0.15 (+0.38%)

, SWAV

ShockWave Medical

$46.00 /

-0.98 (-2.09%)

Catch up on today's…

Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Apple (AAPL) upgraded to Hold from Reduce at HSBC WITH analyst Nicolas Cote-Colisson saying he expects a successful launch of a 5G iPhone in the third quarter of 2020. 2. Keurig Dr Pepper (KDP) upgraded to Buy from Hold at Jefferies with analyst Kevin Grundy saying he groups Keurig Dr Pepper as among the beneficiaries from the work-from-home trend given it has a higher share in the at-home channels. 3. Cardiovascular Systems (CSII) upgraded to Buy from Hold at Needham with analyst Mike Matson saying the company can "resume and sustain" double-digit revenue growth post-COVID-19, driven by new products and geographic expansion. 4. Kirkland Lake Gold (KL) upgraded to Buy from Neutral at Roth Capital with analyst Jake Sekelsky saying with the backdrop of the U.S. entering a recession, increased government spending resulting from the COVID-19 pandemic, interest rates at or possibly below zero, and U.S. unemployment over 13%, precious metals are poised for a "bull cycle" similar to the one seen following the 2008 financial crisis. 5. ShockWave Medical (SWAV) upgraded to Perform from Underperform at Oppenheimer with analyst Suraj Kalia saying consistent with the broader market, ShockWave has rallied about 40% since early April, and now trades at 15-times fiscal year 2021 P/S, one of the highest valuations in med tech-land. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
SWAV ShockWave Medical
$46.00 /

-0.98 (-2.09%)

KL Kirkland Lake Gold
$39.54 /

+0.15 (+0.38%)

KDP Keurig Dr Pepper
$28.99 /

+0.47 (+1.65%)

CSII Cardiovascular Systems
$33.69 /

+0.64 (+1.94%)

AAPL Apple
$349.10 /

-3.51 (-1.00%)

AAPL Apple
$349.10 /

-3.51 (-1.00%)

06/11/20 Wells Fargo
Apple price target raised to $385 from $315 at Wells Fargo
06/11/20 BofA
Apple price target raised to $390 from $340 at BofA
06/11/20 HSBC
HSBC upgrades Apple to Hold, boosts target to $295 from $225
06/10/20 HSBC
Apple upgraded to Hold from Reduce at HSBC
KDP Keurig Dr Pepper
$28.99 /

+0.47 (+1.65%)

06/11/20 Jefferies
Jefferies upgrades work-from-home winner Keurig Dr Pepper to Buy
06/11/20 Jefferies
Keurig Dr Pepper upgraded to Buy from Hold at Jefferies
06/01/20 Evercore ISI
Keurig Dr Pepper upgraded to Outperform from In Line at Evercore ISI
04/01/20 Goldman Sachs
Keurig Dr Pepper resumed with a Neutral at Goldman Sachs
CSII Cardiovascular Systems
$33.69 /

+0.64 (+1.94%)

06/11/20 Needham
Needham upgrades Cardiovascular Systems on 'too compelling' valuation
06/11/20 Needham
Cardiovascular Systems upgraded to Buy from Hold at Needham
05/06/20 Lake Street
Cardiovascular Systems price target lowered to $48 from $54 at Lake Street
04/06/20 Oppenheimer
Cardiovascular Systems initiated with an Outperform at Oppenheimer
KL Kirkland Lake Gold
$39.54 /

+0.15 (+0.38%)

06/11/20 Roth Capital
Kirkland Lake upgraded to Buy on higher gold prices at Roth Capital
06/11/20 Roth Capital
Kirkland Lake Gold upgraded to Buy from Neutral at Roth Capital
05/29/20 BMO Capital
Kirkland Lake Gold upgraded to Outperform from Market Perform at BMO Capital
05/22/20 National Bank
Kirkland Lake downgraded to Sector Perform from Outperform at National Bank
SWAV ShockWave Medical
$46.00 /

-0.98 (-2.09%)

06/11/20 Oppenheimer
ShockWave Medical upgraded to Perform at Oppenheimer
06/11/20 Oppenheimer
ShockWave Medical upgraded to Perform from Underperform at Oppenheimer
06/09/20 Canaccord
ShockWave Medical price target raised to $53 from $46 at Canaccord
06/09/20 Piper Sandler
ShockWave Medical price target raised to $54 from $45 at Piper Sandler
SWAV ShockWave Medical
$46.00 /

-0.98 (-2.09%)

KL Kirkland Lake Gold
$39.54 /

+0.15 (+0.38%)

KDP Keurig Dr Pepper
$28.99 /

+0.47 (+1.65%)

CSII Cardiovascular Systems
$33.69 /

+0.64 (+1.94%)

AAPL Apple
$349.10 /

-3.51 (-1.00%)

  • 10
    Jun
KL Kirkland Lake Gold
$39.54 /

+0.15 (+0.38%)

KDP Keurig Dr Pepper
$28.99 /

+0.47 (+1.65%)

AAPL Apple
$349.10 /

-3.51 (-1.00%)

SWAV ShockWave Medical
$46.00 /

-0.98 (-2.09%)

KDP Keurig Dr Pepper
$28.99 /

+0.47 (+1.65%)

CSII Cardiovascular Systems
$33.69 /

+0.64 (+1.94%)

AAPL Apple
$349.10 /

-3.51 (-1.00%)

KL Kirkland Lake Gold
$39.54 /

+0.15 (+0.38%)

AAPL Apple
$349.10 /

-3.51 (-1.00%)

AAPL Apple
$349.10 /

-3.51 (-1.00%)

Upgrade
Needham upgrades Cardiovascular Systems on 'too compelling' valuation » 05:38
06/11/20
06/11
05:38
06/11/20
05:38
CSII

Cardiovascular Systems

$33.05 /

-5.34 (-13.91%)

Needham analyst Mike…

Needham analyst Mike Matson upgraded Cardiovascular Systems to Buy from Hold with a $44 price target. The company can "resume and sustain" double-digit revenue growth post-COVID-19, driven by new products and geographic expansion, Matson tells investors in a research note. Further, the analyst views the consensus estimates for fiscal 2021 and 2022, which are well below his estimates, as conservative. Matson says that while reimbursement represents an overhang and headline risk, he does not expect any changes for several years. Further, Cardiovascular's recent equity offering strengthens its balance sheet and provides it with increased flexibility, adds the analyst. The stock's valuation has become "too compelling to ignore," contends Matson.

ShowHide Related Items >><<
CSII Cardiovascular Systems
$33.05 /

-5.34 (-13.91%)

CSII Cardiovascular Systems
$33.05 /

-5.34 (-13.91%)

06/11/20 Needham
Cardiovascular Systems upgraded to Buy from Hold at Needham
05/06/20 Lake Street
Cardiovascular Systems price target lowered to $48 from $54 at Lake Street
04/06/20 Oppenheimer
Cardiovascular Systems initiated with an Outperform at Oppenheimer
04/03/20 Lake Street
Cardiovascular Systems price target lowered to $54 from $60 at Lake Street
CSII Cardiovascular Systems
$33.05 /

-5.34 (-13.91%)

  • 10
    Jun
CSII Cardiovascular Systems
$33.05 /

-5.34 (-13.91%)

Upgrade
Cardiovascular Systems upgraded to Buy from Hold at Needham » 05:33
06/11/20
06/11
05:33
06/11/20
05:33
CSII

Cardiovascular Systems

$33.05 /

-5.34 (-13.91%)

Needham analyst Michael…

Needham analyst Michael Matson upgraded Cardiovascular Systems to Buy from Hold with a $44 price target.

ShowHide Related Items >><<
CSII Cardiovascular Systems
$33.05 /

-5.34 (-13.91%)

CSII Cardiovascular Systems
$33.05 /

-5.34 (-13.91%)

05/06/20 Lake Street
Cardiovascular Systems price target lowered to $48 from $54 at Lake Street
04/06/20 Oppenheimer
Cardiovascular Systems initiated with an Outperform at Oppenheimer
04/03/20 Lake Street
Cardiovascular Systems price target lowered to $54 from $60 at Lake Street
10/18/19 Guggenheim
Guggenheim starts 'underestimated' Cardiovascular Systems at Buy
CSII Cardiovascular Systems
$33.05 /

-5.34 (-13.91%)

  • 10
    Jun
CSII Cardiovascular Systems
$33.05 /

-5.34 (-13.91%)

On The Fly
Fly Intel: Pre-market Movers » 09:03
06/10/20
06/10
09:03
06/10/20
09:03
GMAB

Genmab

$28.80 /

+0.37 (+1.30%)

, FULC

Fulcrum Therapeutics

$21.18 /

+1.19 (+5.95%)

, TRUE

TrueCar

$2.89 /

-0.085 (-2.86%)

, DUO

FangDD Network

$60.00 /

+50 (+500.00%)

, LAKE

Lakeland Industries

$20.80 /

+5.2 (+33.33%)

, UNFI

United Natural Foods

$22.40 /

-0.2 (-0.88%)

, RRGB

Red Robin

$17.01 /

-2.17 (-11.31%)

, CMCM

Cheetah Mobile

$3.45 /

+0.02 (+0.58%)

, GME

GameStop

$4.75 /

-0.25 (-5.00%)

, SBUX

Starbucks

$82.37 /

-1.22 (-1.46%)

, SALT

Scorpio Bulkers

$18.85 /

-5.84 (-23.65%)

, CSII

Cardiovascular Systems

$36.00 /

-5.29 (-12.81%)

Check out this morning's…

Open Full Text

ShowHide Related Items >><<
UNFI United Natural Foods
$22.40 /

-0.2 (-0.88%)

TRUE TrueCar
$2.89 /

-0.085 (-2.86%)

SBUX Starbucks
$82.37 /

-1.22 (-1.46%)

SALT Scorpio Bulkers
$18.85 /

-5.84 (-23.65%)

RRGB Red Robin
$17.01 /

-2.17 (-11.31%)

LAKE Lakeland Industries
$20.80 /

+5.2 (+33.33%)

GME GameStop
$4.75 /

-0.25 (-5.00%)

GMAB Genmab
$28.80 /

+0.37 (+1.30%)

FULC Fulcrum Therapeutics
$21.18 /

+1.19 (+5.95%)

DUO FangDD Network
$60.00 /

+50 (+500.00%)

CSII Cardiovascular Systems
$36.00 /

-5.29 (-12.81%)

CMCM Cheetah Mobile
$3.45 /

+0.02 (+0.58%)

GMAB Genmab
$28.80 /

+0.37 (+1.30%)

06/03/20 Barclays
Genmab price target raised to DKK 2,150 from DKK 1,700 at Barclays
06/03/20 H.C. Wainwright
H.C. Wainwright reiterates Buy on Genmab, says ofatumumab delay not impactful
06/03/20 Bryan Garnier
Genmab downgraded to Neutral from Buy at Bryan Garnier
06/02/20 SunTrust
Genmab price target raised to $36 from $30 at SunTrust
FULC Fulcrum Therapeutics
$21.18 /

+1.19 (+5.95%)

03/06/20 H.C. Wainwright
Fulcrum Therapeutics price target raised to $28 from $21 at H.C. Wainwright
12/24/19 H.C. Wainwright
Fulcrum 2020 data may support accelerated approval, says H.C. Wainwright
10/03/19 H.C. Wainwright
Fulcrum Therapeutics initiated with a Buy at H.C. Wainwright
08/12/19 Morgan Stanley
Fulcrum Therapeutics initiated with an Overweight at Morgan Stanley
TRUE TrueCar
$2.89 /

-0.085 (-2.86%)

06/10/20 B. Riley FBR
B. Riley FBR upgrades TrueCar to Buy on improving auto trends
06/10/20 B. Riley FBR
TrueCar upgraded to Buy from Neutral at B. Riley FBR
03/13/20 Stephens
Stephens still sees 'decent chance' of TrueCar being acquired
02/21/20 Craig-Hallum
TrueCar price target lowered to $4 from $5 at Craig-Hallum
DUO FangDD Network
$60.00 /

+50 (+500.00%)

LAKE Lakeland Industries
$20.80 /

+5.2 (+33.33%)

06/10/20 Benchmark
Lakeland Industries price target raised to $31 after 'blow-out' at Benchmark
06/09/20 Benchmark
Benchmark starts PPE maker Lakeland Industries at Buy
06/09/20 Benchmark
Lakeland Industries initiated with a Buy at Benchmark
04/15/20 Roth Capital
Lakeland Industries resumed with a Buy at Roth Capital
UNFI United Natural Foods
$22.40 /

-0.2 (-0.88%)

05/15/20 BMO Capital
United Natural Foods price target raised to $22 from $10 at BMO Capital
05/13/20
Fly Intel: Top five analyst upgrades
05/13/20 Wells Fargo
United Natural Foods upgraded to Equal Weight on COVID benefits at Wells Fargo
05/13/20 Wells Fargo
United Natural Foods upgraded to Equal Weight from Underweight at Wells Fargo
RRGB Red Robin
$17.01 /

-2.17 (-11.31%)

02/26/20 Wells Fargo
Red Robin price target lowered to $30 from $35 at Wells Fargo
01/15/20 Maxim
Red Robin seeing early signs of turnaround, says Maxim
11/06/19 Loop Capital
Red Robin price target lowered to $33 from $36 at Loop Capital
09/05/19 Stephens
Red Robin back to 'trust me' story after takeover rejection, says Stephens
CMCM Cheetah Mobile
$3.45 /

+0.02 (+0.58%)

08/05/19 Jefferies
Cheetah Mobile initiated with an Underperform at Jefferies
06/17/19 Nomura Instinet
Cheetah Mobile price target loured to $3.60 from $7 at Nomura Instinet
GME GameStop
$4.75 /

-0.25 (-5.00%)

06/10/20 Baird
GameStop significant challenges remain ahead, says Baird
04/21/20 Baird
GameStop FY20 EPS target cut at Baird
03/27/20 Baird
GameStop trneds to remain weak despite recent increase, says Baird
03/20/20
Fly Intel: Top five analyst downgrades
SBUX Starbucks
$82.37 /

-1.22 (-1.46%)

06/09/20 BTIG
Beyond Meat's China distribution to accelerate sales in second half, says BTIG
05/28/20 Cleveland Research
Starbucks U.S. comp improvement to be moderate, says Cleveland Research
05/21/20 William Blair
Starbucks comps continuing to improve in both U.S. and China, says William Blair
05/21/20 Stephens
Starbucks tempered near-term expectations in update, says Stephens
SALT Scorpio Bulkers
$18.85 /

-5.84 (-23.65%)

04/20/20 BTIG
Scorpio Bulkers, Golden Ocean price targets cut at BTIG
02/04/20 Pareto
Scorpio Bulkers upgraded to Buy from Hold at Pareto
01/28/20 B. Riley FBR
Scorpio Bulkers price target lowered to $6.50 from $9.50 at B. Riley FBR
01/27/20 Fearnley
Scorpio Bulkers downgraded to Hold from Buy at Fearnley
CSII Cardiovascular Systems
$36.00 /

-5.29 (-12.81%)

05/06/20 Lake Street
Cardiovascular Systems price target lowered to $48 from $54 at Lake Street
04/06/20 Oppenheimer
Cardiovascular Systems initiated with an Outperform at Oppenheimer
04/03/20 Lake Street
Cardiovascular Systems price target lowered to $54 from $60 at Lake Street
10/18/19 Guggenheim
Guggenheim starts 'underestimated' Cardiovascular Systems at Buy
UNFI United Natural Foods
$22.40 /

-0.2 (-0.88%)

TRUE TrueCar
$2.89 /

-0.085 (-2.86%)

SBUX Starbucks
$82.37 /

-1.22 (-1.46%)

SALT Scorpio Bulkers
$18.85 /

-5.84 (-23.65%)

RRGB Red Robin
$17.01 /

-2.17 (-11.31%)

LAKE Lakeland Industries
$20.80 /

+5.2 (+33.33%)

GME GameStop
$4.75 /

-0.25 (-5.00%)

GMAB Genmab
$28.80 /

+0.37 (+1.30%)

FULC Fulcrum Therapeutics
$21.18 /

+1.19 (+5.95%)

DUO FangDD Network
$60.00 /

+50 (+500.00%)

CSII Cardiovascular Systems
$36.00 /

-5.29 (-12.81%)

CMCM Cheetah Mobile
$3.45 /

+0.02 (+0.58%)

  • 10
    Jun
  • 10
    Jun
SBUX Starbucks
$82.37 /

-1.22 (-1.46%)

LAKE Lakeland Industries
$20.80 /

+5.2 (+33.33%)

GME GameStop
$4.75 /

-0.25 (-5.00%)

CMCM Cheetah Mobile
$3.45 /

+0.02 (+0.58%)

UNFI United Natural Foods
$22.40 /

-0.2 (-0.88%)

TRUE TrueCar
$2.89 /

-0.085 (-2.86%)

SBUX Starbucks
$82.37 /

-1.22 (-1.46%)

SALT Scorpio Bulkers
$18.85 /

-5.84 (-23.65%)

RRGB Red Robin
$17.01 /

-2.17 (-11.31%)

LAKE Lakeland Industries
$20.80 /

+5.2 (+33.33%)

GME GameStop
$4.75 /

-0.25 (-5.00%)

CSII Cardiovascular Systems
$36.00 /

-5.29 (-12.81%)

CMCM Cheetah Mobile
$3.45 /

+0.02 (+0.58%)

UNFI United Natural Foods
$22.40 /

-0.2 (-0.88%)

SBUX Starbucks
$82.37 /

-1.22 (-1.46%)

RRGB Red Robin
$17.01 /

-2.17 (-11.31%)

LAKE Lakeland Industries
$20.80 /

+5.2 (+33.33%)

GME GameStop
$4.75 /

-0.25 (-5.00%)

Syndicate
Cardiovascular Systems 3.676M share Spot Secondary priced at $34.00 » 06:19
06/10/20
06/10
06:19
06/10/20
06:19
CSII

Cardiovascular Systems

$36.00 /

-5.29 (-12.81%)

The deal range was…

The deal range was $33.00-$35.00. Barclays and SVB Leerink acted as joint book running managers for the offering.

ShowHide Related Items >><<
CSII Cardiovascular Systems
$36.00 /

-5.29 (-12.81%)

CSII Cardiovascular Systems
$36.00 /

-5.29 (-12.81%)

05/06/20 Lake Street
Cardiovascular Systems price target lowered to $48 from $54 at Lake Street
04/06/20 Oppenheimer
Cardiovascular Systems initiated with an Outperform at Oppenheimer
04/03/20 Lake Street
Cardiovascular Systems price target lowered to $54 from $60 at Lake Street
10/18/19 Guggenheim
Guggenheim starts 'underestimated' Cardiovascular Systems at Buy
CSII Cardiovascular Systems
$36.00 /

-5.29 (-12.81%)

  • 10
    Jun
CSII Cardiovascular Systems
$36.00 /

-5.29 (-12.81%)

Syndicate
Cardiovascular Systems files to sell $125M in common stock » 16:10
06/09/20
06/09
16:10
06/09/20
16:10
CSII

Cardiovascular Systems

$38.36 /

-2.93 (-7.10%)

Barclays and SVB Leerink…

Barclays and SVB Leerink are acting as joint book-running managers for the offering.

ShowHide Related Items >><<
CSII Cardiovascular Systems
$38.36 /

-2.93 (-7.10%)

CSII Cardiovascular Systems
$38.36 /

-2.93 (-7.10%)

05/06/20 Lake Street
Cardiovascular Systems price target lowered to $48 from $54 at Lake Street
04/06/20 Oppenheimer
Cardiovascular Systems initiated with an Outperform at Oppenheimer
04/03/20 Lake Street
Cardiovascular Systems price target lowered to $54 from $60 at Lake Street
10/18/19 Guggenheim
Guggenheim starts 'underestimated' Cardiovascular Systems at Buy
CSII Cardiovascular Systems
$38.36 /

-2.93 (-7.10%)

CSII Cardiovascular Systems
$38.36 /

-2.93 (-7.10%)

Recommendations
Cardiovascular Systems price target lowered to $48 from $54 at Lake Street » 08:41
05/06/20
05/06
08:41
05/06/20
08:41
CSII

Cardiovascular Systems

$41.38 /

+1.53 (+3.84%)

Lake Street analyst…

Lake Street analyst Brooks O'Neil lowered the firm's price target on Cardiovascular Systems to $48 from $54 as he lowered his forecast to reflect the elevated impact Of COVID-19 after the company reported lower than expected Q3 revenues. While disruption of procedure volume and delays in inventory restocking turned out to have a greater impact than he'd expected, O'Neil keeps a Buy rating on Cardiovascular Systems shares as he has "high confidence" in the company's ability to continue to effectively operate and "adequate liquidity to weather the COVID-19 storm."

ShowHide Related Items >><<
CSII Cardiovascular Systems
$41.38 /

+1.53 (+3.84%)

04/06/20 Oppenheimer
Cardiovascular Systems initiated with an Outperform at Oppenheimer
04/03/20 Lake Street
Cardiovascular Systems price target lowered to $54 from $60 at Lake Street
10/18/19 Guggenheim
Guggenheim starts 'underestimated' Cardiovascular Systems at Buy
10/17/19 Guggenheim
Cardiovascular Systems initiated with a Buy at Guggenheim

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.